| ESTRO ACROP consensus guideline on CT-and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer C Salembier, G Villeirs, B De Bari, P Hoskin, BR Pieters, M Van Vulpen, ... Radiotherapy and Oncology 127 (1), 49-61, 2018 | 221 | 2018 |
| EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU … JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ... European urology 77 (2), 223-250, 2020 | 195 | 2020 |
| Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database S Salas, N Resseguier, JY Blay, A Le Cesne, A Italiano, C Chevreau, ... Annals of oncology 28 (8), 1779-1787, 2017 | 149 | 2017 |
| Adaptive radiotherapy for head and neck cancer J Castelli, A Simon, C Lafond, N Perichon, B Rigaud, E Chajon, B De Bari, ... Acta Oncologica 57 (10), 1284-1292, 2018 | 124 | 2018 |
| Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO … SGC Kroeze, M Pavic, K Stellamans, Y Lievens, C Becherini, M Scorsetti, ... The lancet oncology 24 (3), e121-e132, 2023 | 96 | 2023 |
| EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU … A Horwich, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ... Annals of Oncology 30 (11), 1697-1727, 2019 | 90 | 2019 |
| Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy J Castelli, B De Bari, A Depeursinge, A Simon, A Devillers, GR Jimenez, ... Critical reviews in oncology/hematology 108, 40-51, 2016 | 72 | 2016 |
| Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: a review F Alongi, B De Bari, F Campostrini, S Arcangeli, DV Matei, E Lopci, ... Critical reviews in oncology/hematology 88 (3), 550-563, 2013 | 67 | 2013 |
| pMineR: an innovative R library for performing process mining in medicine R Gatta, J Lenkowicz, M Vallati, E Rojas, A Damiani, L Sacchi, B De Bari, ... Artificial Intelligence in Medicine: 16th Conference on Artificial …, 2017 | 65 | 2017 |
| Four years with FALCON–an ESTRO educational project: achievements and perspectives JG Eriksen, C Salembier, S Rivera, B De Bari, D Berger, G Mantello, ... Radiotherapy and Oncology 112 (1), 145-149, 2014 | 61 | 2014 |
| Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms M Balducci, S Chiesa, S Manfrida, E Rossi, T Za, V Frascino, B De Bari, ... Strahlentherapie und Onkologie 187 (2), 114, 2011 | 56 | 2011 |
| Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist J Cacicedo, A Navarro, O Del Hoyo, A Gomez-Iturriaga, F Alongi, ... The British journal of radiology 89 (1067), 20160217, 2016 | 54 | 2016 |
| Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies M Balducci, A Fiorentino, P De Bonis, S Chiesa, S Manfrida, ... Medical Oncology 29, 3478-3483, 2012 | 52 | 2012 |
| The “BUONGIORNO” project: burnout syndrome among young Italian radiation oncologists P Ciammella, B De Bari, A Fiorentino, P Franco, S Cavuto, F Alongi, L Livi, ... Cancer investigation 31 (8), 522-528, 2013 | 50 | 2013 |
| Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study M Balducci, S Chiesa, B Diletto, GR D'Agostino, A Mangiola, S Manfrida, ... Neuro-oncology 14 (1), 79-86, 2012 | 50 | 2012 |
| Spinal metastases: Is stereotactic body radiation therapy supported by evidences? B De Bari, F Alongi, G Mortellaro, R Mazzola, L Schiappacasse, ... Critical reviews in oncology/hematology 98, 147-158, 2016 | 49 | 2016 |
| Extreme hypofractionation for early prostate cancer: biology meets technology B De Bari, S Arcangeli, D Ciardo, R Mazzola, F Alongi, EG Russi, ... Cancer treatment reviews 50, 48-60, 2016 | 45 | 2016 |
| Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus BA Jereczek-Fossa, G Marvaso, M Zaffaroni, SG Gugliandolo, D Zerini, ... Cancer treatment reviews 98, 102206, 2021 | 44 | 2021 |
| 50-Gy stereotactic body radiation therapy to the dominant intraprostatic nodule: results from a phase 1a/b trial FG Herrera, M Valerio, D Berthold, T Tawadros, JY Meuwly, V Vallet, ... International Journal of Radiation Oncology* Biology* Physics 103 (2), 320-334, 2019 | 41 | 2019 |
| A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study L Nicosia, D Franceschini, F Perrone-Congedi, F Casamassima, ... Radiotherapy and Oncology 166, 92-99, 2022 | 38 | 2022 |
Filippo AlongiDirettore Radioterapia Oncologica, Ospedale Sacro Cuore, Negrar (Verona)Verified email at sacrocuore.it
